Macrogenics (MGNX) Stock Price, Quote & News

Company Profile

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic can...

Industry: Biotechnology

Sector: Healthcare

Phone: 301 251 5172

Fax: 301 251 5321

Website: www.macrogenics.com

Address:

9704 Medical Center Drive, Rockville, United States

chole1 Jun. 2 at 7:36 PM

$MGNX and the daily intraday slide is on again... what a terrible biotech tape!

1 · Reply

SuperGreenToday Jun. 2 at 6:03 PM

$MGNX Share Price: $4.10 Contract Selected: Jan 15, 2027 $5 Calls Buy Zone: $0.68 – $0.84 Target Zone: $1.15 – $1.40 Potential Upside: 59% ROI Time to Expiration: 226 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Budman10 May. 30 at 5:06 PM

$MGNX Still trading below cash on hand value. $0 priced in for their drug pipeline or future royalty payments No dilution in sight for years. Way under priced.

1 · Reply

Budman10 May. 30 at 3:00 AM

$MGNX Shitty week, but some consolidation seems natural

1 · Reply

MarketBeat May. 27 at 10:05 AM

https://marketbeat.com/a/8677968/ $MGNX MacroGenics Eyes $200M Cash Boost, 2028 Runway Ahead of Cancer Pipeline Updates

0 · Reply

PMD777 May. 26 at 11:33 AM

$MGNX Green Day and trying to put out $4.51 ask- come on MM

0 · Reply

stockhold1 May. 22 at 8:10 PM

$MGNX $5 next week

0 · Reply

Budman10 May. 22 at 5:15 PM

$MGNX Need this sucker over $5 to get get rid of penny stock stigma. Get those funds to start buying in

0 · Reply

PMD777 May. 22 at 1:21 PM

$MGNX I’m guessing that they drop the press release at open and rip to 52wk high

0 · Reply

biolover May. 22 at 12:30 PM

$MGNX Another impressive activity to B7 H4 ADC now in PDAC. Reflects well on $MGNX that may potentially have BIC ( no ILD so far ..) phase 1 data mid year .. $MRK molecule with 12% ILD. Big problem in real life.

3 · Reply

MacroGenics Transcript: Stifel 2026 Targeted Oncology Virtual Forum

May 14, 2026, 4:01 PM EDT - 23 days ago

MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum

2026-05-13T20:39:44.000Z - 24 days ago

MacroGenics reports Q1 EPS (58c), consensus (55c)

May 13, 2026, 4:01 PM EDT - 24 days ago

MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation

May 13, 2026, 7:00 AM EDT - 24 days ago

MacroGenics Quarterly report: Q1 2026

May 13, 2026, 7:00 AM EDT - 24 days ago

MacroGenics Earnings release: Q1 2026

2026-05-11T22:48:03.000Z - 26 days ago

MacroGenics to sell GMP manufacturing operations to Bora for $122.5M upfront

2026-05-11T22:40:45.000Z - 26 days ago

MacroGenics trading resumes

May 11, 2026, 5:20 PM EDT - 26 days ago

MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals

2026-05-11T20:33:29.000Z - 26 days ago

MacroGenics trading halted, news pending

2026-05-04T11:49:28.000Z - 4 weeks ago

MacroGenics, Sagard enter expanded Zynyz royalty purchase agreement

INCY

May 4, 2026, 7:30 AM EDT - 4 weeks ago

MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement

Apr 22, 2026, 8:00 AM EDT - 6 weeks ago

MacroGenics Proxy statement: Proxy filing

2026-04-20T09:25:08.000Z - 6 weeks ago

MacroGenics price target raised to $6 from $4 at Barclays

2026-04-10T11:06:12.000Z - 2 months ago

MacroGenics upgraded to Buy at B. Riley after deal for Tubulus

GILD

2026-04-10T10:55:12.000Z - 2 months ago

MacroGenics upgraded to Buy from Neutral at B. Riley

2026-04-08T20:37:37.000Z - 2 months ago

MacroGenics says FDA removes partial clinical hold on Phase 2 LINNET study

Apr 8, 2026, 4:30 PM EDT - 2 months ago

FDA Removes Partial Clinical Hold on MacroGenics' LINNET Study

Apr 8, 2026, 8:00 AM EDT - 2 months ago

MacroGenics Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 2 months ago

MacroGenics Proxy statement: Proxy filing

Mar 12, 2026, 10:00 AM EDT - 3 months ago

MacroGenics Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 11, 2026, 10:45 AM EDT - 3 months ago

MacroGenics Transcript: The Citizens Life Sciences Conference 2026

Mar 10, 2026, 1:40 PM EDT - 3 months ago

MacroGenics Transcript: Leerink Global Healthcare Conference 2026

2026-03-10T09:15:35.000Z - 3 months ago

MacroGenics price target raised to $4 from $3 at Barclays

Mar 9, 2026, 4:01 PM EDT - 3 months ago

MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures

Mar 9, 2026, 7:00 AM EDT - 3 months ago

MacroGenics Earnings release: Q4 2025

Mar 9, 2026, 7:00 AM EDT - 3 months ago

MacroGenics Annual report: Q4 2025

Mar 9, 2026, 7:00 AM EDT - 3 months ago

MacroGenics Slides: Corporate presentation

Mar 3, 2026, 3:10 PM EST - 3 months ago

MacroGenics Transcript: TD Cowen 46th Annual Health Care Conference

Feb 26, 2026, 5:30 PM EST - 3 months ago

MacroGenics to Participate in Upcoming Investor Conferences

2026-02-23T23:20:15.000Z - 3 months ago

MacroGenics says FDA places partial clinical hold on Phase 2 LINNET study

Feb 23, 2026, 6:14 PM EST - 3 months ago

MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial

Dec 4, 2025, 7:55 AM EST - 6 months ago

MacroGenics Transcript: Evercore ISI 8th Annual HealthCONx Conference

Nov 25, 2025, 4:05 PM EST - 6 months ago

MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference

Nov 13, 2025, 4:00 PM EST - 7 months ago

MacroGenics Transcript: Stifel 2025 Healthcare Conference

Nov 12, 2025, 6:00 PM EST - 7 months ago

MacroGenics Slides: Corporate Presentation

2025-11-12T21:23:19.000Z - 7 months ago

MacroGenics reports Q3 EPS 27c vs 90c last year

2025-11-12T21:22:50.000Z - 7 months ago

MacroGenics expects cash to fund operations into late 2027

Nov 12, 2025, 4:01 PM EST - 7 months ago

MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress

Nov 12, 2025, 2:30 AM EST - 7 months ago

MacroGenics Earnings release: Q3 2025

Nov 12, 2025, 2:30 AM EST - 7 months ago

MacroGenics Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 7 months ago

MacroGenics to Participate in the Stifel 2025 Healthcare Conference

2025-09-16T20:50:19.000Z - 9 months ago

MacroGenics assumed with an Overweight at Barclays

2025-09-16T20:20:17.000Z - 9 months ago

MacroGenics initiated with an Overweight at Barclays

Sep 8, 2025, 11:30 AM EDT - 9 months ago

MacroGenics Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 4:30 PM EDT - 9 months ago

MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference

2025-08-15T11:35:33.000Z - 10 months ago

MacroGenics price target lowered to $5 from $8 at Leerink

2025-08-14T20:12:11.000Z - 10 months ago

MacroGenics reports Q2 EPS (57c), consensus (38c)

Aug 14, 2025, 4:01 PM EDT - 10 months ago

MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities

Aug 14, 2025, 7:00 AM EDT - 10 months ago

MacroGenics Earnings release: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 10 months ago

MacroGenics Quarterly report: Q2 2025

2025-08-13T20:05:31.000Z - 10 months ago

MacroGenics CEO Scott Koenig steps down, Eric Risser succeeds

Aug 13, 2025, 4:01 PM EDT - 10 months ago

MacroGenics Appoints Eric Risser as President and Chief Executive Officer

Jun 10, 2025, 8:00 AM EDT - 1 year ago

MacroGenics Transcript: Goldman Sachs 46th Annual Global Healthcare Conference 2025

2025-06-10T11:10:08.000Z - 1 year ago

MacroGenics, Sagard Healthcare enter into ZYNYZ royalty purchase

Jun 10, 2025, 7:00 AM EDT - 1 year ago

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement

Jun 10, 2025, 7:00 AM EDT - 1 year ago

MacroGenics Slides: Corporate Presentation

Jun 3, 2025, 4:30 PM EDT - 1 year ago

MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

May 13, 2025, 4:01 PM EDT - 1 year ago

MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results

May 13, 2025, 3:30 AM EDT - 1 year ago

MacroGenics Earnings release: Q1 2025

May 13, 2025, 3:30 AM EDT - 1 year ago

MacroGenics Quarterly report: Q1 2025

May 8, 2025, 10:30 AM EDT - 1 year ago

MacroGenics Transcript: The Citizens JMP Life Sciences Conference 2025

May 6, 2025, 4:30 PM EDT - 1 year ago

MacroGenics Announces Date of First Quarter 2025 Financial Results

May 1, 2025, 4:30 PM EDT - 1 year ago

MacroGenics to Participate in Upcoming Investor Conference

Apr 11, 2025, 8:00 AM EDT - 1 year ago

MacroGenics Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

MacroGenics Proxy statement: Proxy Filing

Mar 19, 2025, 4:30 PM EDT - 1 year ago

MacroGenics Earnings Call Transcript: Q4 2024

Mar 19, 2025, 4:30 PM EDT - 1 year ago

MacroGenics Earnings release: Q4 2024

Mar 19, 2025, 4:30 PM EDT - 1 year ago

MacroGenics Annual report: Q4 2024

Mar 12, 2025, 2:00 PM EDT - 1 year ago

MacroGenics Transcript: Barclays 27th Annual Global Healthcare Conference

Mar 11, 2025, 11:20 AM EDT - 1 year ago

MacroGenics Transcript: Leerink’s Global Healthcare Conference 2025

Mar 6, 2025, 7:30 AM EST - 1 year ago

MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call

Mar 5, 2025, 10:30 AM EST - 1 year ago

MacroGenics Transcript: TD Cowen 45th Annual Healthcare Conference

Dec 4, 2024, 7:30 AM EST - 1 year ago

MacroGenics Transcript: 7th Annual Evercore ISI HealthCONx Healthcare Conference

Nov 18, 2024, 1:15 PM EST - 1 year ago

MacroGenics Transcript: Stifel 2024 Healthcare Conference

Nov 12, 2024, 4:00 PM EST - 1 year ago

MacroGenics Transcript: Guggenheim Securities Inaugural Healthcare Innovation Conference

Nov 5, 2024, 4:01 PM EST - 1 year ago

MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

Nov 5, 2024, 2:30 AM EST - 1 year ago

MacroGenics Earnings Call Transcript: Q3 2024

Nov 5, 2024, 2:30 AM EST - 1 year ago

MacroGenics Earnings release: Q3 2024

Nov 5, 2024, 2:30 AM EST - 1 year ago

MacroGenics Quarterly report: Q3 2024

Oct 30, 2024, 7:30 AM EDT - 1 year ago

MacroGenics Announces Leadership Transition

Oct 29, 2024, 4:30 PM EDT - 1 year ago

MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

Oct 25, 2024, 5:15 PM EDT - 1 year ago

Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders

Oct 22, 2024, 7:30 AM EDT - 1 year ago

MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®

Sep 17, 2024, 11:04 AM EDT - 1 year ago

Hospice Dynamix Welcomes Industry Veteran Rob Stoltz as Chief Strategy Officer

chole1 Jun. 2 at 7:36 PM

$MGNX and the daily intraday slide is on again... what a terrible biotech tape!

1 · Reply

SuperGreenToday Jun. 2 at 6:03 PM

0 · Reply

Budman10 May. 30 at 5:06 PM

$MGNX Still trading below cash on hand value. $0 priced in for their drug pipeline or future royalty payments No dilution in sight for years. Way under priced.

1 · Reply

Budman10 May. 30 at 3:00 AM

$MGNX Shitty week, but some consolidation seems natural

1 · Reply

MarketBeat May. 27 at 10:05 AM

https://marketbeat.com/a/8677968/ $MGNX MacroGenics Eyes $200M Cash Boost, 2028 Runway Ahead of Cancer Pipeline Updates

0 · Reply

PMD777 May. 26 at 11:33 AM

$MGNX Green Day and trying to put out $4.51 ask- come on MM

0 · Reply

stockhold1 May. 22 at 8:10 PM

$MGNX $5 next week

0 · Reply

Budman10 May. 22 at 5:15 PM

$MGNX Need this sucker over $5 to get get rid of penny stock stigma. Get those funds to start buying in

0 · Reply

PMD777 May. 22 at 1:21 PM

$MGNX I’m guessing that they drop the press release at open and rip to 52wk high

0 · Reply

biolover May. 22 at 12:30 PM

3 · Reply

PMD777 May. 22 at 10:55 AM

$MGNX no one posts here much, but after the 5% haircut it’s bid/ask is $4.40/$4.83 with volume of 14k

0 · Reply

Budman10 May. 20 at 6:17 PM

$MGNX It was a good/positive call/forum today. Eric seems very excited and optimistic about the next corporate update call.

0 · Reply

shoagh12 May. 20 at 1:35 PM

$MGNX

0 · Reply

bundy3333 May. 19 at 3:35 PM

$MGNX G O T C H A # 2 After having reached USD 3,28 a little bit later in April, now we are at USD 4,50. Time to rethink. Any idea regarding time frame and potential price target?

1 · Reply

stockhold1 May. 18 at 6:14 PM

$MGNX Are we heading in that direction?

1 · Reply

1Knevrenuff May. 18 at 2:46 PM

$MGNX

0 · Reply

Budman10 May. 16 at 4:39 AM

$MGNX Double digits baby

1 · Reply

1Knevrenuff May. 15 at 2:12 PM

$MGNX

0 · Reply

PMD777 May. 15 at 11:42 AM

$MGNX boom

1 · Reply

GoCubsGo1124 May. 14 at 8:33 PM

$MGNX everything that has popped up on my recent scanner has doubled within 4 to 6 months. Can this do the same?

2 · Reply

LewisDaKat May. 14 at 8:30 PM

$MGNX MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum https://marketwirenews.com/stock/mgnx/news/macrogenics-to-participate-in-the-stifel-2026-virtua-5365263585998456.html?utm_source=stocktwits

0 · Reply

PMD777 May. 14 at 8:23 PM

$CRDF these low volume names don’t immediately respond to ER. May we get a $MGNX type response from the enough cash to finish the year.

0 · Reply

Market Cap	266.97M
Revenue (ttm)	149.50M
Net Income (ttm)	-74.62M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-49.91%
Debt to Equity Ratio	0.00

Volume	560,000
Avg Vol	1,060,630
Day's Range	N/A - N/A
Shares Out	63.56M
Stochastic %K	39%
Beta	1.18
Analysts	Sell
Price Target	$6.75